BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment

L. P. Ormerod*, H. J. Milburn, S. Gillespie, J. Ledingham, D. Rampton

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

411 Citations (Scopus)

Abstract

Guidelines have been compiled by The Joint Tuberculosis Committee of the British Thoracic Society to quantify the risks of reactivation of tuberculosis with anti-tumour necrosis factor α (anti-TNF-α) treatment. These guidelines are intended to inform respiratory physicians, gastroenterologists, rheumatologists and dermatologists, together with specialist nurses in those disciplines.

Original languageEnglish
Pages (from-to)800-805
Number of pages6
JournalThorax
Volume60
Issue number10
DOIs
Publication statusPublished - 1 Oct 2005

Fingerprint

Dive into the research topics of 'BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment'. Together they form a unique fingerprint.

Cite this